Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome | Zendy

Tobias F. Kröpelin | Zendy; Dick de Zeeuw | Zendy; Frank A. Holtkamp | Zendy; David Packham | Zendy; Hiddo J.L. Heerspink | Zendy

Open Access

Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome

Author(s) -

Tobias F. Kröpelin,

Dick de Zeeuw,

Frank A. Holtkamp,

David Packham,

Hiddo J.L. Heerspink

Publication year - 2016

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfv429

Subject(s) - albuminuria , medicine , urology , receiver operating characteristic , endocrinology , kidney disease

Albuminuria reduction due to angiotensin receptor blockers (ARBs) predicts subsequent renoprotection. Relating the initial albuminuria reduction to subsequent renoprotection assumes that the initial ARB-induced albuminuria reduction remains stable during follow-up. The aim of this study was to assess individual albuminuria fluctuations after the initial ARB response and to determine whether taking individual albuminuria fluctuations into account improves renal outcome prediction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research